Accepted at 3:20 p.m. Oct, 31, 2023 by Alex
Author: khu002
Related Note: 1485227039136
Rationale for change

matches the other card that says what aspects of parkinson's that trihexyphenidyl and benztropine treat

Extra Extra
Text
Trihexyphenidyl and benztropine are not useful for treating the {{c1::bradykinesia}} of Parkinson disease
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Parkinsonism Drugs
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Dementia : Parkinson Disease

Watch associated Bootcamp video - Autonomic System : Muscarinic Antagonists
OME

Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#Bootcamp::Neurology::Dementia::Parkinson_Disease
#AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::12_Benztropine/Trihexyphenidyl #AK_Original_Decks::Step_1::Zanki_Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::09_Muscarinic_Antagonists !AK_UpdateTags::AnKing_Image::MS::Extrapyramidal_symptoms #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::08_Muscarinic_Antagonists::M1_Antagonists #AK_Step1_v12::#OME_banner #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::01_Parkinson's_Disease #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield !AK_UpdateTags::AnKing_Image::Mujeeb::Extrapyramidal_symptoms #AK_Step1_v12::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::08_Parkinson_Disease_Therapy #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#B&B::15_Neuro::07_Other::08_Parkinsons,_Huntingtons,_&_Movement_Disorders #AK_Step1_v12::#Bootcamp::Neurology::26_Dementia::02_Parkinson_Disease #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::04_Antipsychotics_&_Parkinsons::03_Parkinsonism_Drugs #AK_Step1_v12::#FirstAid::12_Neuro_&_Special_Senses::06_Pharm::08_Parkinson_Disease_Therapy::M1_Muscarinic_Antagonists